Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06150950 · ClinicalTrials.gov registry record · NA
REHAB Fontan Failure: A Trial of Cardiac Rehabilitation
A NA study of Single-ventricle and Heart Failure Congenital, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 2
- Study locations
NCT06150950: Recruiting NA study of Single-ventricle and Heart Failure Congenital, sponsored by Stanford University.
NCT06150950 is a NA study of Single-ventricle and Heart Failure Congenital that is actively recruiting participants, run by Stanford University. The registered enrollment target is 50 participants, below the 84-participant average among 17 other Single-ventricle trials with a reported enrollment target (40% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06150950, a NA study of Single-ventricle and Heart Failure Congenital, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to compare the impact of cardiac rehabilitation on Fontan failure patients' exertional tolerance, frailty, and quality of life. 1. Among patients with Fontan failure, will cardiac rehabilitation increase average daily steps compared to usual care? 2. Among patients with Fontan failure, will cardiac rehabilitation improve exertional tolerance (as measured by cardiopulmonary exercise testing), frailty, and self-reported quality of life metrics compared to usual care?
Primary Outcome
Average daily step count during the intervention period measured by Fitbit 3 activity tracker
Conditions Studied
Interventions
- OTHER Usual care
- BEHAVIORAL Cardiac rehabilitation
Study Locations (2)
California
- Stanford University - Stanford
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-05-05 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06150950 shows while recruiting
NCT06150950 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 84-participant average among 17 other Single-ventricle trials with a reported enrollment target (40% lower).
The record links to 2 conditions, with Single-ventricle appearing as the primary indexed condition, and to 2 interventions - of which Usual care is the first listed.
NCT06150950 reports a single indexed study location in California, Tennessee.
Frequently Asked Questions
What is clinical trial NCT06150950 about?
NCT06150950 is a clinical study titled "REHAB Fontan Failure: A Trial of Cardiac Rehabilitation". The goal of this clinical trial is to compare the impact of cardiac rehabilitation on Fontan failure patients' exertional tolerance, frailty, and quality of life. 1. Among patients with Fontan failure, will cardiac rehabilitation increase average daily steps compared to usual care? 2. Among patient...
What is the current status of trial NCT06150950?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-05-05. Estimated completion is 2026-12-31.
What conditions does trial NCT06150950 study?
This clinical trial studies the following conditions: Single-ventricle, Heart Failure Congenital.
What interventions are being tested in trial NCT06150950?
The interventions under investigation include: Usual care (OTHER), Cardiac rehabilitation (BEHAVIORAL).
Who is sponsoring clinical trial NCT06150950?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06150950 being conducted?
This trial has 2 study locations across California, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Single-ventricle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06150950's enrollment target sits among peer trials
50 8th of 17 higher than 9 of 17 other Single-ventricle trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Single-ventricle trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fontan Fitness Trial
RECRUITING · NA
-
Re-Energize Fontan
RECRUITING · NA
-
Ventripoint Single Ventricle Study
RECRUITING · NA
-
Association of Near Infrared Spectroscopy With Interstage Outcomes
RECRUITING · NA
-
Enhanced External Counterpulsation in Patients With Fontan Circulation
COMPLETED · NA
-
Improving Functional Capacity in Fontan Patients Through Inspiratory Muscle Training
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI